Medinice S.A. (WSE:ICE)
Poland · Delayed Price · Currency is PLN 16.00
+2.02 (14.45%)
Dec 15, 2025, 4:49 PM CET
Medinice Revenue
Medinice had revenue of 19.00K PLN in the twelve months ending September 30, 2025, down -91.28% year-over-year. In the year 2024, Medinice had annual revenue of 188.00K, down -16.44%.
Revenue (ttm)
19.00K
Revenue Growth
-91.28%
P/S Ratio
5,662.38
Revenue / Employee
1.73K
Employees
11
Market Cap
107.59M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 188.00K | -37.00K | -16.44% |
| Dec 31, 2023 | 225.00K | -21.00K | -8.54% |
| Dec 31, 2022 | 246.00K | -39.00K | -13.68% |
| Dec 31, 2021 | 285.00K | -87.00K | -23.39% |
| Dec 31, 2020 | 372.00K | 208.00K | 126.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.34B |
| Diagnostyka | 2.30B |
| Centrum Medyczne ENEL-MED | 820.59M |
| Synektik Spólka Akcyjna | 623.20M |
| Voxel | 568.83M |
| Selvita | 373.90M |
| Celon Pharma | 225.60M |
| Ryvu Therapeutics | 90.41M |